{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:22:40Z","timestamp":1791411760866,"version":"4.3.3"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ecl.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T08:30:18Z","timestamp":1386837018000},"page":"103-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":266,"title":["Type 2 Diabetes Mellitus and Hypertension"],"prefix":"10.1016","volume":"43","author":[{"given":"Guido","family":"Lastra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Romayne","family":"Kurukulasuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2013.09.005_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","article-title":"Diabetes, hypertension, and cardiovascular disease: an update","volume":"37","author":"Sowers","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000322822","article-title":"The role of overweight and obesity in the cardiorenal syndrome","volume":"1","author":"Sowers","year":"2011","journal-title":"Cardiorenal Med"},{"issue":"5","key":"10.1016\/j.ecl.2013.09.005_bib3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/HYPERTENSIONAHA.111.00612","article-title":"Diabetes mellitus and vascular disease","volume":"61","author":"Sowers","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/eurheartj\/ehm501","article-title":"Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease","volume":"28","author":"Hu","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ecl.2013.09.005_bib6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcm.2010.08.001","article-title":"Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study","volume":"20","author":"Fox","year":"2010","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.110.162446","article-title":"Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2013.09.005_bib10","first-page":"1","article-title":"Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008","volume":"35","author":"Wright","year":"2011","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.ecl.2013.09.005_bib11","series-title":"Kaplan's clinical hypertension","first-page":"1","article-title":"Hypertension in the population at large","author":"Kaplan","year":"2010"},{"key":"10.1016\/j.ecl.2013.09.005_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/404107","article-title":"Quality of life, depression, and healthcare resource utilization among adults with type 2 diabetes mellitus and concomitant hypertension and obesity: a prospective survey","author":"Green","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.ecl.2013.09.005_bib13","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1185\/03007990802297529","article-title":"The burden of illness of hypertension and comorbid diabetes","volume":"24","author":"Eaddy","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ecl.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2337\/diacare.15.10.1277","article-title":"Greater effect of glycemia on incidence of hypertension in women than in men","volume":"15","author":"Haffner","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00125-003-1096-6","article-title":"Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes","volume":"46","author":"Hu","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.110.168005","article-title":"Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis","volume":"57","author":"Carson","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.jhh.1000740","article-title":"Ten-year incidence of elevated blood pressure and its predictors: the CARDIA Study, Coronary Artery Risk Development in (Young) Adults","volume":"13","author":"Dyer","year":"1999","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/297588a0","article-title":"Racial differences in hypertension-associated red cell sodium permeability","volume":"297","author":"Etkin","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2013.09.005_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpt109","article-title":"Is the association of diabetes with uncontrolled blood pressure stronger in Mexican Americans and Blacks than in Whites among diagnosed hypertensive patients?","author":"Liu","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2012.40","article-title":"Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010","volume":"307","author":"Ogden","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2337\/dc12-2420","article-title":"Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial","volume":"36","author":"TODAY Study Group","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ecl.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","article-title":"Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension","volume":"287","author":"Boustany","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib25","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2013.09.005_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pcad.2009.12.004","article-title":"Aldosterone: role in the cardiometabolic syndrome and resistant hypertension","volume":"52","author":"Whaley-Connell","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ecl.2013.09.005_bib27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ecl.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","article-title":"A\u00a0novel adipokine CTRP1 stimulates aldosterone production","volume":"22","author":"Jeon","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ecl.2013.09.005_bib29","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature: molecular and cellular mechanisms","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ecl.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ecl.2013.09.005_bib33","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ecl.2013.09.005_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","article-title":"T\u00a0regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury","volume":"57","author":"Barhoumi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.numecd.2007.05.002","article-title":"Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database","volume":"18","author":"Bonora","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ecl.2013.09.005_bib38","first-page":"523","article-title":"Insulin action and insulin resistance in vascular endothelium","volume":"10","author":"Muniyappa","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11892-003-0018-9","article-title":"Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium","volume":"3","author":"Vincent","year":"2003","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ecl.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ecl.2013.09.005_bib41","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00092.2005","article-title":"Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production","volume":"289","author":"Potenza","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib42","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/me.2005-0266","article-title":"Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1\u00a0via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium","volume":"20","author":"Formoso","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ecl.2013.09.005_bib43","doi-asserted-by":"crossref","first-page":"H1937","DOI":"10.1152\/ajpheart.00868.2006","article-title":"Phosphatidylinositol 3-kinase\/protein kinase Akt negatively regulates plasminogen activator inhibitor type-1 expression in vascular endothelial cells","volume":"292","author":"Mukai","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib44","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationship between insulin resistance and endothelial dysfunction","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2013.09.005_bib45","first-page":"1037","article-title":"Small artery structure and function in hypertension","volume":"14","author":"Heagerty","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib46","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2013.09.005_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00004872-200103001-00001","article-title":"Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)","volume":"19","author":"Landsberg","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI119532","article-title":"Receptor-mediated regional sympathetic nerve activation by leptin","volume":"100","author":"Haynes","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2013.09.005_bib49","doi-asserted-by":"crossref","first-page":"F1055","DOI":"10.1152\/ajprenal.00108.2005","article-title":"Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats","volume":"290","author":"Song","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib50","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.0711283105","article-title":"Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor","volume":"105","author":"Tiwari","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2013.09.005_bib51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","article-title":"Effect of insulin on renal sodium and uric acid handling in essential hypertension","volume":"9","author":"Muscelli","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1751-7176.2011.00570.x","article-title":"Evidence-based hypertension treatment in patients with diabetes","volume":"14","author":"Garcia-Touza","year":"2012","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ecl.2013.09.005_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib54","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes\u20132011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2013.09.005_bib56","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators","volume":"340","author":"Tuomilehto","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib58","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2013.09.005_bib59","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s001250050629","article-title":"Appropriate blood pressure control in NIDDM (ABCD) trial","volume":"39","author":"Schrier","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2013.09.005_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2013.09.005_bib61","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes-2013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2011.09.040","article-title":"Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)","volume":"59","author":"Redon","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib63","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2013.09.005_bib64","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.110.160523","article-title":"Intensive blood pressure control affects cerebral blood flow in type 2 diabetes mellitus patients","volume":"57","author":"Kim","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/dc12-0755","article-title":"Generic medications and blood pressure control in diabetic hypertensive subjects: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"36","author":"Cummings","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/dc10-0676","article-title":"Effects of the dietary approaches to stop hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients","volume":"34","author":"Azadbakht","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib69","first-page":"1083","article-title":"The dietary approaches to stop hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients","volume":"141","author":"Azadbakht","year":"2011","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ecl.2013.09.005_bib70","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1253\/circj.CJ-12-0164","article-title":"Lifestyle changes through the use of delivered meals and dietary counseling in a single-blind study. The STYLIST study","volume":"76","author":"Noda","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.ecl.2013.09.005_bib71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2013.09.005_bib72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/oxfordjournals.aje.a009668","article-title":"Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I","volume":"148","author":"Cook","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib73","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane Review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ancard.2013.03.001","article-title":"Sodium restriction prevents cardiovascular remodeling associated with insulin-resistance in the rat","volume":"62","author":"Rugale","year":"2013","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.ecl.2013.09.005_bib75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a metaanalysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib77","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2013.09.005_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib80","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib81","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: Candesartan Antihypertensive Survival Evaluation in Japan Trial","volume":"51","author":"Ogihara","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib82","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0140-6736(04)17015-3","article-title":"VALUE: analysis of results","volume":"364","author":"Fretheim","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib83","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib84","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1681\/ASN.2006060560","article-title":"Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial","volume":"17","author":"Ruggenenti","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ecl.2013.09.005_bib85","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-151-1-200907070-00120","article-title":"Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials","volume":"5","author":"Bilous","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib87","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ecl.2013.09.005_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","article-title":"Role of aldosterone and angiotensin II in insulin resistance: an update","volume":"71","author":"Lastra-Lastra","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2013.09.005_bib89","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib90","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.21.4.597","article-title":"Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM","volume":"21","author":"Tatti","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib91","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.HYP.0000231662.77359.de","article-title":"Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack trial","volume":"48","author":"Leenen","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib92","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib94","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/HJH.0b013e328310e0d9","article-title":"The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes","volume":"26","author":"Ostergren","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib95","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2013.09.005_bib96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.109.142620","article-title":"Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity","volume":"55","author":"Manrique","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/HYPERTENSIONAHA.109.139592","article-title":"Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications","volume":"55","author":"Cooper-DeHoff","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.112.194787","article-title":"Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients","volume":"60","author":"Raheja","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib99","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/HYPERTENSIONAHA.109.145136","article-title":"Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat","volume":"55","author":"Zhou","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.ecl.2013.09.005_bib101","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/diab.42.11.1678","article-title":"Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9\u201339) an antagonist of the receptor","volume":"42","author":"Thorens","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2013.09.005_bib102","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/en.2003-0007","article-title":"Cardiac function in mice lacking the glucagon-like peptide-1 receptor","volume":"144","author":"Gros","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2013.09.005_bib103","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1476-5381.2009.00376.x","article-title":"Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?","volume":"157","author":"Grieve","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ecl.2013.09.005_bib104","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2013.09.005_bib105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/dc09-2062","article-title":"Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database","volume":"33","author":"Horton","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.09.005_bib106","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0091270008316885","article-title":"Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension","volume":"48","author":"Mistry","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ecl.2013.09.005_bib107","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats","volume":"154","author":"Aroor","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2013.09.005_bib108","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.phrs.2009.06.004","article-title":"The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart","volume":"60","author":"Ossum","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ecl.2013.09.005_bib110","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00174.2007","article-title":"Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule","volume":"294","author":"Girardi","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib111","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/HJH.0b013e328341939d","article-title":"Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats","volume":"29","author":"Pacheco","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib112","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clinthera.2012.02.004","article-title":"Single-pill combination of telmisartan\/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial","volume":"34","author":"Sharma","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.ecl.2013.09.005_bib113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"Weber","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2013.09.005_bib114","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib116","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03261832","article-title":"Triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study","volume":"12","author":"Chrysant","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ecl.2013.09.005_bib117","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/tmj.2010.0176","article-title":"Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial","volume":"17","author":"Wakefield","year":"2011","journal-title":"Telemed J E Health"},{"key":"10.1016\/j.ecl.2013.09.005_bib118","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MNH.0b013e3283641a89","article-title":"Renal nerves in blood pressure regulation","volume":"22","author":"Johns","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ecl.2013.09.005_bib119","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Symplicity HTN-2 Investigators","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2013.09.005_bib120","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2013.09.005_bib121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.112.000949","article-title":"Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension","volume":"128","author":"Mahfoud","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2013.09.005_bib122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","article-title":"Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension","volume":"51","author":"Fagard","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2013.09.005_bib123","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMra060433","article-title":"Ambulatory blood-pressure monitoring","volume":"354","author":"Pickering","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:37:42Z","timestamp":1760175462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852913000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0889852913000923"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2013.09.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 Diabetes Mellitus and Hypertension","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}